cephalosporin c has been researched along with cem 101 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandes, P; Golparian, D; Jensen, JS; Ohnishi, M; Unemo, M | 1 |
| Rademacher, J; Welte, T | 1 |
1 review(s) available for cephalosporin c and cem 101
| Article | Year |
|---|---|
[New antibiotics - standstill or progress].
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Ceftaroline; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ephedrine; Humans; Macrolides; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Penicillanic Acid; Phenobarbital; Staphylococcal Infections; Tazobactam; Theophylline; Triazoles | 2017 |
1 other study(ies) available for cephalosporin c and cem 101
| Article | Year |
|---|---|
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment op
Topics: Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Culture Media; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Macrolides; Microbial Sensitivity Tests; Molecular Structure; Neisseria gonorrhoeae; Triazoles | 2012 |